AI Podcast Interviews Articles and Reports
Our podcast interviews feature the best and brightest executives and researchers in artificial intelligence today, and each episode highlights current and near-term AI use-cases of value for business leaders. Explore our full list of AI podcast episodes below:
Dr. Patrick Hopkins is a philosopher and bioethicist. In this interview, we don't contemplate traditional bioethic concerns of animal testing or disease treatment. Instead, we discuss some important considerations of how emerging technologies might alter our bodies, minds, personalities and gender – and, indeed, what "human" might imply in the first place.
Since the inception of the discipline of artificial intelligence (AI) in the 1950s, progress in the field has advanced at a rapid pace. We have seen the development of early neural networks, game AI, the Turing Test, and theories involving expert systems and intelligent agents, but according to Ben Goertzel, there is a specific element of AI today that is significantly missing.
Augmented Reality (AR)—a live view of a real-world situation with extra elements supplied by computer-generated sensory input—is a rapidly advancing field in high technology. Pete Wassell is the founder and CEO of Augmate, a B2B augmented reality enterprise that is on the cutting edge of AR.
While California may have Silicon Valley, it's New England that's making waves in the angel investment community, and Chris Mirabile is one of the people leading the way. Mirabile is the co-managing director of Launchpad Venture Group, the largest angel group in New England.
The fields of biology and technology are becoming increasingly intertwined. Without computers, sequencing the human genome would have remained a pipe dream. Additionally, some of the most fascinating advances in computing technology have come from observing and replicating aspects of the biological world. This “bits to bio and bio to bits” approach is the core of Charles Fracchia’s world. Fracchia, an IBM PhD Fellow at the Center for Bits and Atoms at MIT and Church Lab at Harvard Medical School, is the founder of BioBright.org, which makes open-source tools for laboratories and medical devices.
In this episode, I interview Douglas Burdett, the founder of Artillery Marketing. Douglas discusses the importance of "zeroing in" on buyer persona, along with the nuances and key differences of marketing B2B versus B2C.